MC
Muhlenkamp & Co Portfolio holdings
AUM
$320M
This Quarter Return
+31.56%
1 Year Return
+26.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$187M
AUM Growth
–
Cap. Flow
+$187M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
55.88%
Holding
31
New
31
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
$16.8M |
| 2 |
Apple
AAPL
|
$14.3M |
| 3 |
SPDR Gold Trust
GLD
|
$11.6M |
| 4 |
McKesson
MCK
|
$10.8M |
| 5 |
Microchip Technology
MCHP
|
$10M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 26.22% |
| 2 | Healthcare | 25.1% |
| 3 | Consumer Discretionary | 14.38% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $782K | 0.42% |
+23,922
| New | +$782K |
|
|
GMLP
27
DELISTED
Golar LNG Partners LP
GMLP
| $664K | 0.36% |
+257,367
| New | +$664K |
|
28
Morgan Stanley
MS
$240B
| $522K | 0.28% |
+10,805
| New | +$522K |
|
29
Enterprise Products Partners
EPD
$69.6B
| $452K | 0.24% |
+24,855
| New | +$452K |
|
30
Cognizant
CTSH
$35.3B
| $340K | 0.18% |
+5,981
| New | +$340K |
|
|
BMY.RT
31
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $251K | 0.13% |
+70,121
| New | +$251K |
|